The invention relates to an improved process for synthesis of anti-Parkinson compound from commercially available (R)-benzyl glycidyl ether, wherein the compound obtained has enantiopurity greater than >98%.
Patent No:
US9475757
Application No:
14/888697
Filing Date:
02-11-2015
Issue Date:
25-10-2016
Applicant:
CSIR-National Chemical Laboratory (CSIR-NCL), Pune
Disclaimer:
Information available on this portal is sourced from various organizations and is provided for informational purposes only. Users are advised to verify details from the respective official sources.
Please enter your details
Please provide your name and email to continue. Your details are saved in this browser for future use.
Latest Updates
Loading…
⚠️
You are leaving this website
You are about to be redirected to an external website that is not operated by
India Science, Technology & Innovation (ISTI) Portal.
Acces sibility Controls